Uniphar plc

UPR

IE00BJ5FQX74

Pharmaceuticals

Market Closed - Irish S.E. Other stock markets 11:55:00 2024-04-26 am EDT			5-day change	1st Jan Change
2.52 ^EUR	+0.40%		-0.20%	-6.67%

Feb. 27	Uniphar ups full-year dividend as profit falls but revenue climbs	AN
Feb. 27	Uniphar Seeks M&A	CI

Uniphar half-year trading in line with expectations

July 26, 2023 at 06:14 am EDT

Uniphar PLC - Dublin-based healthcare services company - Says gross profit and earnings before tax, depreciation and amortisation for the six months to June 30 are in line with its expectations due to strong performance. Notes interim organic gross profit growth is over 5%, driven by outperformance in its Supply Chain & Retail division.

Current stock price: 256.00 pence, down 3.8% on Wednesday

12-month change: down 15%

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Latest news about Uniphar plc

Uniphar ups full-year dividend as profit falls but revenue climbs	Feb. 27	AN
Uniphar Seeks M&A	Feb. 27	CI
Transcript : Uniphar plc, 2023 Earnings Call, Feb 27, 2024	Feb. 27
Uniphar's FY23 Profit Edges Down; Revenue Grows	Feb. 27	MT
Earnings Flash (UPR.L) UNIPHAR Reports FY23 EPS EUR0.16	Feb. 27	MT
Uniphar plc Recommends Final Dividend, Payable on 14 May 2024	Feb. 27	CI
Uniphar plc Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Uniphar set to meet annual profit and earnings expectations	Jan. 30	AN
Uniphar plc Announces Executive Changes	Jan. 30	CI
Uniphar plc Announces Resignation of Jeffrey Berkowitz from the Board	Jan. 17	CI
Uniphar non-exec director buys EUR115,000 worth of shares	23-10-09	AN
Uniphar non-exec chair buys EUR200,000 worth of shares	23-10-06	AN
Uniphar executives Rabbette and Dolphin buy shares	23-10-04	AN
Uniphar revenue up on divisional growth; sets out earnings target	23-09-14	AN
Transcript : Uniphar plc, H1 2023 Earnings Call, Sep 14, 2023	23-09-14
Uniphar Posts Drop in H1 Attributable Profit; Revenue Rises	23-09-14	MT
Earnings Flash (UPR.L) UNIPHAR Reports H1 Revenue EUR1.24B	23-09-14	MT
Earnings Flash (UPR.L) UNIPHAR Reports H1 EPS EUR0.06	23-09-14	MT
Uniphar plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-14	CI
Uniphar plc Declares Interim Dividend for the Period to 30 June 2023, Payable on 20 October 2023	23-09-14	CI
Uniphar Group Appoints Kay Bonavita as Chief Commercial Officer for Uniphar Logistics to Lead the US Team Based Out of Raleigh, North Carolina	23-08-10	CI
FTSE 100 Closes Down 0.2% as Miners Offset Ocado, Rolls-Royce Jumps	23-07-26	DJ
Uniphar half-year trading in line with expectations	23-07-26	AN
Uniphar Sees Over 5% Uptick in H1 Organic Gross Profit	23-07-26	MT
FTSE 100 Closes Thursday Down 0.1% After BOE Rate Hike	23-05-11	DJ

Chart Uniphar plc

Duration

Period

More charts

Company Profile

Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,800, the Group is active in Ireland, the United Kingdom, the Benelux, the Nordics, Germany and the United States. The Company's vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar plc represents a strong combination of scale, growth and profitability.

Sector

Pharmaceuticals

Calendar

2024-05-09 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Uniphar plc

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.52 EUR

Average target price

4.25 EUR

Spread / Average Target

+68.65%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
UNIPHAR PLC	-6.67%	734M
MCKESSON CORPORATION	+17.35%	71.39B
CARDINAL HEALTH, INC.	+2.39%	25.1B
SINOPHARM GROUP CO. LTD.	+5.38%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.69%	8.19B
HUADONG MEDICINE CO., LTD	-20.96%	7.91B
H. LUNDBECK A/S	+0.49%	4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.31B
EBOS GROUP LIMITED	-3.38%	3.93B
GALENICA AG	-2.61%	3.86B

Pharmaceuticals Wholesale

Uniphar plc

Equities

UPR

IE00BJ5FQX74

Pharmaceuticals

Uniphar half-year trading in line with expectations

EPS Revisions